Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hyperthermic stimulation of blood increases the immunological effects of granulocyte and monocyte adsorption in vitro: relevance to extracorporeal immunomodulation.
Tozawa K, Fukunaga K, Kamikozuru K, Ohnishi K, Hida N, Ohda Y, Kusaka T, Yoshida K, Jinno Y, Nagase K, Nakamura S, Miwa H, Matsumoto T. Tozawa K, et al. Among authors: nagase k. Transfus Apher Sci. 2008 Oct;39(2):129-35. doi: 10.1016/j.transci.2008.07.012. Transfus Apher Sci. 2008. PMID: 18762459
Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.
Kikuyama R, Fukunaga K, Kawai M, Yokoyama Y, Kamikozuru K, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Kato K, Kono T, Nogami K, Nagase K, Nakamura S, Takei Y, Miwa H, Matsumoto T. Kikuyama R, et al. Among authors: nagase k. Ther Apher Dial. 2011 Aug;15(4):360-6. doi: 10.1111/j.1744-9987.2011.00968.x. Ther Apher Dial. 2011. PMID: 21884470
Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.
Yoshida K, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, Yokoyama Y, Iimuro M, Takeda N, Kato K, Kikuyama R, Nagase K, Hori K, Nakamura S, Miwa H, Matsumoto T. Yoshida K, et al. Among authors: nagase k. Inflamm Bowel Dis. 2012 Sep;18(9):1617-23. doi: 10.1002/ibd.21928. Epub 2011 Nov 13. Inflamm Bowel Dis. 2012. PMID: 22081474 Clinical Trial.
Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitis.
Fukunaga K, Kamikozuru K, Yokoyama Y, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Kikuyama R, Kato K, Nagase K, Nakamura S, Miwa H, Matsumoto T. Fukunaga K, et al. Among authors: nagase k. J Clin Apher. 2011 Dec;26(6):326-31. doi: 10.1002/jca.20314. Epub 2011 Nov 14. J Clin Apher. 2011. PMID: 22083887 Clinical Trial.
Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
Yokoyama Y, Kawai M, Fukunaga K, Kamikozuru K, Nagase K, Nogami K, Kono T, Ohda Y, Iimuro M, Hida N, Nakamura S, Miwa H, Matsumoto T. Yokoyama Y, et al. Among authors: nagase k. BMC Gastroenterol. 2013 Feb 12;13:27. doi: 10.1186/1471-230X-13-27. BMC Gastroenterol. 2013. PMID: 23399416 Free PMC article.
366 results